Sgrna Target Selection
Sgrna Target Selection - Related Videos
02:15
Nanoblade-Based Delivery of Nucleic Acid Cargo: A Technique to Deliver Cas9-sgRNA Complex to Target Cells via Virus-Like Particles
0 Views •
2025
This video demonstrates a technique for nanoblade-based delivery of Cas9-sgRNA ribonucleoprotein complex inside target cells for genome editing. Nanoblades are virus-like particles devoid of the ability to multiply and infect neighboring cells, therefore are very useful for rapid and dose-dependent transportation of bio- and nanomaterials.
01:23
Ethics in Target Audience Selection
0 Views •
2024
Ethics in targeting audiences is a crucial aspect of marketing and business practices. It involves understanding and respecting the rights, interests, and dignity of consumers while conducting any promotional activities or communications. Unethical targeting can lead to exploitation, manipulation, or harm, particularly for vulnerable groups like children, older people, or those with low financial literacy. Ethical targeting respects consumer privacy, avoids intrusive advertising, and ensures...
04:51
High-Efficiency Gene Disruption in Primary Bone Marrow-Derived Macrophages Using Electroporated Cas9-sgRNA Complexes
0 Views •
2023
This protocol describes the procedure for genome editing in mouse bone marrow-derived macrophages using Cas9-sgRNA ribonucleoprotein complexes assembled in vitro and delivered by electroporation.
05:22
Using Phage Display to Select Proteins with High Affinity to a Target Protein
0 Views •
2025
In this video, we demonstrate the phage display technique to isolate pre-engineered phages expressing proteins with high affinity to the target protein.
10:44
In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
0 Views •
Cited by 2 •
2023
Here, we present a protocol for the in vitro selection of engineered transcriptional repressors (ETRs) with high, long-term, stable, on-target silencing efficiency and low genome-wide, off-target activity. This workflow allows for reducing an initial, complex repertoire of candidate ETRs to a short list, suitable for further evaluation in therapeutically relevant settings.
FAQs
A candidate guide must be evaluated together with its protospacer-adjacent motif (PAM), because sequence complementarity alone does not establish that the CRISPR-associated nuclease can recognize the site. The PAM provides a compatibility condition for targeting, so sites lacking the required motif may be unsuitable even when the guide sequence matches the intended genomic region. This check narrows the design options.
Complementarity determines how closely an sgRNA corresponds to its intended DNA sequence. Strong correspondence supports targeting of the selected genomic site, whereas similar sequences elsewhere can create potential off-target activity. Reviewing both the intended match and possible additional matches helps distinguish guides that are more likely to support specific editing from those that could complicate experimental interpretation.
PAM compatibility is only one part of evaluating a candidate site. Nearby sequence features may influence cleavage efficiency and the likelihood of off-target activity, so guides should not be chosen from sequence matching alone. Considering these local features helps researchers compare candidates more effectively and select designs that better balance activity at the intended site with specificity across the genome.
Different candidate sites can vary in PAM compatibility, nearby sequence features, expected cleavage efficiency, and potential matches elsewhere in the genome. Comparing them allows researchers to prioritize a guide with a more favorable specificity profile rather than relying on one sequence match. This selection process improves experimental reliability and strengthens conclusions drawn from the resulting genetic or expression changes.
A basic workflow begins by identifying candidate guide sequences near the genomic site of interest. Researchers then check sequence complementarity, confirm a compatible PAM, examine nearby features that may affect cleavage or off-target activity, and compare possible matches elsewhere in the genome. The final guide choice reflects this combined evaluation rather than any single sequence characteristic.
The selected guide can be used to direct a CRISPR-associated nuclease toward a site chosen for gene disruption, sequence modification, or regulation of gene expression. The appropriate candidate therefore depends on the intended experimental outcome, while specificity remains important in each case. Matching guide selection to the genetic objective helps connect the targeted site with the question being tested.
A guide with potential matches elsewhere in the genome may produce effects that are not attributable solely to the intended target. Minimizing such off-target possibilities makes observed phenotypic changes easier to interpret as consequences of the planned genetic intervention. In genetics, this consideration supports more reliable links between a selected genomic site, the resulting molecular change, and the measured phenotype.